GSK approached us with a brief to conceptualise and manage the opening of its first facility in Singapore purpose built to make small batches of highly potent active pharmaceutical ingredients with high toxicity. The challenge was to make the scientific nature of its work into a compelling and insightful narrative for its different stakeholders within GSK and externally, for guests within the pharma sector and the media.
Managing the opening of the new high potency plant meant that we had to consider the intricacies of its production and what could be shared in the public domain. We found fresh applications of the new GSK branding in the messaging, presentation and delivery of the event and brand assets and ensured that the communications disseminated had a balance of local and international relevance.
The event was well received by the senior leadership who saw the new GSK brand in action and managed with confidence by the local teams onsite.